Gut Microbiota in Anxiety and Depression: Unveiling the Relationships and Management Options

Pharmaceuticals (Basel). 2023 Apr 9;16(4):565. doi: 10.3390/ph16040565.

Abstract

The gut microbiota is critical for maintaining human health and the immunological system. Several neuroscientific studies have shown the significance of microbiota in developing brain systems. The gut microbiota and the brain are interconnected in a bidirectional relationship, as research on the microbiome-gut-brain axis shows. Significant evidence links anxiety and depression disorders to the community of microbes that live in the gastrointestinal system. Modified diet, fish and omega-3 fatty acid intake, macro- and micro-nutrient intake, prebiotics, probiotics, synbiotics, postbiotics, fecal microbiota transplantation, and 5-HTP regulation may all be utilized to alter the gut microbiota as a treatment approach. There are few preclinical and clinical research studies on the effectiveness and reliability of various therapeutic approaches for depression and anxiety. This article highlights relevant research on the association of gut microbiota with depression and anxiety and the different therapeutic possibilities of gut microbiota modification.

Keywords: anxiety; depression; gut–brain axis; microbiota; probiotics.

Publication types

  • Review

Grants and funding

This project was supported by the fundamental research fund, Chiang Mai University, Chiang Mai, Thailand.